Pulmonary Endarterectomy Guided by CT Scanning for Patients With Chronic Thromboembolic Pulmonary Hypertension----PEACT
PEACT
The Precise Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Endarterectomy Guided by Three-dimensional Pulmonary Angiography
1 other identifier
interventional
72
1 country
1
Brief Summary
This study is a effectiveness study of the application of high-definition enhanced computed-tomography for patients with chronic thromboembolic pulmonary hypertension(CTEPH).The patients with CTEPH was randomized into 2 groups,precise pulmonary endarterectomy group(guided by enhanced CT scanning) and traditional pulmonary endarterectomy group,the hemodynamic changes tested with right sided heart catherization from baseline to post-operative period and end-point including peri-operative deaths,follow-up mortality,follow-up parameters of ultrasonic cardiogram(UCG),right-sided heart catherization(RHC),nuclear magnetic resonance imaging(MRI),cardiac pulmonary exercise test(CPET) are documented,so as to compare the prognosis between these 2 groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 19, 2018
CompletedFirst Posted
Study publicly available on registry
January 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJanuary 8, 2019
December 1, 2018
3.3 years
December 19, 2018
January 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change from Baseline pulmonary systolic pressure within 1 month
Systolic pulmonary pressure result tested by right-sided heart
within 1 month before and after pulmonary endarterectomy surgery
Change from Baseline pulmonary mean pressure within 1 month
Mean pulmonary pressure result tested by right-sided heart
within 1 month before and after pulmonary endarterectomy surgery
Change from Baseline pulmonary vascular resistance within 1 month
Pulmonary vascular resistance result tested by right-sided heart
within 1 month before and after pulmonary endarterectomy surgery
Change from Baseline cardiac output within 1 month
Cardiac output result tested by right-sided heart
within 1 month before and after pulmonary endarterectomy surgery
mortality rate after surgery
mortality rate after surgery
immediately after the surgery to the longest 48 months follow-up period
Secondary Outcomes (8)
Follow-up right ventricular ejection fraction
3-24 months after the surgeries
Follow-up tricuspid annular plane systolic excursion
3-24 months after the surgeries
Follow-up right ventricular anterior-posterior diameter
3-24 months after the surgeries
Follow-up tricuspid insufficiency level
3-24 months after the surgeries
Follow-up peak oxygen consumption (Peak O2) result
6-24 months after the surgeries
- +3 more secondary outcomes
Study Arms (2)
Precise
EXPERIMENTALprecise PEA therapy with the guide of 3-D imaging techniques
Placebo
PLACEBO COMPARATORtraditional PEA therapy solely by surgical probe and traditional CT scanning/pulmonary angiography method
Interventions
For patients in Group 1,precisely analyzed CT scanning and/or pulmonary angiography will be done,and the patients in Group 1 will receive PEA procedure with the guide of precise 3-D imaging techniques
Eligibility Criteria
You may qualify if:
- Definite diagnosed with chronic thromboembolic pulmonary hypertension with the right-sided cathrization and pulmonary angiography;
- The computed tomography imaging implied that the location of the embolism could be reached with surgeries;
You may not qualify if:
- Beyond the age limit described above,or combined with other severe conditions such as severe organ dysfunction and considered contraindicated for surgical therapy by the cardiac surgeons;
- Without the consent by the patient or his/her families;
- Acute pulmonary embolism;
- Pulmonary sarcoma;
- Pulmonary arteritis;
- Combined with cardiogenic pulmonary hypertension or idiopathic pulmonary hypertension;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sheng Liulead
Study Sites (1)
Fuwai Hospital,Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100044, China
Related Publications (7)
Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003 Nov;76(5):1457-62; discussion 1462-4. doi: 10.1016/s0003-4975(03)00828-2.
PMID: 14602267BACKGROUNDPengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004 May 27;350(22):2257-64. doi: 10.1056/NEJMoa032274.
PMID: 15163775BACKGROUNDCoquoz N, Weilenmann D, Stolz D, Popov V, Azzola A, Fellrath JM, Stricker H, Pagnamenta A, Ott S, Ulrich S, Gyorik S, Pasquier J, Aubert JD. Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. Eur Respir J. 2018 Apr 4;51(4):1702505. doi: 10.1183/13993003.02505-2017. Print 2018 Apr.
PMID: 29563171BACKGROUNDKirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States. Curr Med Res Opin. 2011 Sep;27(9):1763-8. doi: 10.1185/03007995.2011.604310. Epub 2011 Jul 27.
PMID: 21793646BACKGROUNDDelcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barbera JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jais X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.
PMID: 26826181BACKGROUNDInami T, Kataoka M, Ando M, Fukuda K, Yoshino H, Satoh T. A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS One. 2014 Apr 11;9(4):e94587. doi: 10.1371/journal.pone.0094587. eCollection 2014.
PMID: 24728482BACKGROUNDPepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barbera JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jais X, Simonneau G. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3.
PMID: 21969018BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Adult Cardiac Surgery Center
Study Record Dates
First Submitted
December 19, 2018
First Posted
January 8, 2019
Study Start
February 1, 2017
Primary Completion
May 31, 2020
Study Completion
December 31, 2022
Last Updated
January 8, 2019
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share
We have yet no plan to share IPD with other researchers